December 11, 2008 | Merck is creating a new generics division, clearly indicating the struggle Big Pharma is having over patents. The new division plans to file three new drugs with the FDA this year. Forbes.
For reprints and/or copyright permission, please contact Jay Mulhern, (781) 972-1359, email@example.com.
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: firstname.lastname@example.org
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesreportsbarnett educational servicesconsultingpublications & eNewslettersprofessional services
executive teamtestimonialschi timelinemailing listcareers